Andrew J Mannes

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Measurement of resiniferatoxin in serum samples by high-performance liquid chromatography
    Andrew J Mannes
    DASS NIH, Building 49, Room 1A08, 49 Convent Drive Bethesda, MD 20892, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 823:184-8. 2005
  2. ncbi request reprint Measurement of resiniferatoxin in cerebrospinal fluid by high-performance liquid chromatography
    Andrew J Mannes
    PPCS DASS NIDCR NIH, National Institutes of Health, Building 10, Room 1N117, Rockville Pike, Bethesda, MD 20892, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 780:475-9. 2002
  3. pmc Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1
    Douglas R Stewart
    Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Building 49, Room 4A62, Bethesda, MD 20892, USA
    J Med Genet 47:525-32. 2010
  4. doi request reprint Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome
    Eliezer Soto
    Pain and Palliative Care Service, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA
    Am J Hosp Palliat Care 29:308-17. 2012
  5. ncbi request reprint Cystatin C as a cerebrospinal fluid biomarker for pain in humans
    Andrew J Mannes
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA
    Pain 102:251-6. 2003
  6. pmc Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control
    Laszlo Karai
    National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892, USA
    J Clin Invest 113:1344-52. 2004
  7. ncbi request reprint Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model
    Dorothy Cimino Brown
    Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104 6010, USA
    Anesthesiology 103:1052-9. 2005
  8. ncbi request reprint Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells
    Robert M Caudle
    Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry and the University of Florida McKnight Brain Institute, 1600 Archer Road, P O Box 100416, Gainesville, FL 32610, USA
    Neurotoxicology 24:895-908. 2003
  9. ncbi request reprint Complete pain relief: potential problems and diagnostic solutions
    Andrew J Mannes
    Department of Anesthesia and Surgical Services, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892 4410, USA
    Nat Clin Pract Neurol 3:648-9. 2007
  10. pmc Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia
    John K Neubert
    College of Dentistry Department of Orthodontics, University of Florida, Gainesville, FL, USA
    Mol Pain 4:3. 2008

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Measurement of resiniferatoxin in serum samples by high-performance liquid chromatography
    Andrew J Mannes
    DASS NIH, Building 49, Room 1A08, 49 Convent Drive Bethesda, MD 20892, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 823:184-8. 2005
    ..Therefore, the procedure described provides a useful assay for determination of serum RTX pharmacokinetic parameters...
  2. ncbi request reprint Measurement of resiniferatoxin in cerebrospinal fluid by high-performance liquid chromatography
    Andrew J Mannes
    PPCS DASS NIDCR NIH, National Institutes of Health, Building 10, Room 1N117, Rockville Pike, Bethesda, MD 20892, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 780:475-9. 2002
    ..This assay was applied to measure CSF RTX content to test this method for research and clinical applications related to studies examining its analgesia effects...
  3. pmc Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1
    Douglas R Stewart
    Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Building 49, Room 4A62, Bethesda, MD 20892, USA
    J Med Genet 47:525-32. 2010
    ..Glomus tumours of the fingers and toes are associated with the monogenic disorder neurofibromatosis type 1 (NF1) and are recently recognised as part of the NF1 phenotype...
  4. doi request reprint Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome
    Eliezer Soto
    Pain and Palliative Care Service, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA
    Am J Hosp Palliat Care 29:308-17. 2012
    ..However, patients in the palliative care and hospice setting, especially the one at the end of their lives, may also benefit from oral ketamine even if an intravenous trial is not feasible...
  5. ncbi request reprint Cystatin C as a cerebrospinal fluid biomarker for pain in humans
    Andrew J Mannes
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA
    Pain 102:251-6. 2003
    ..These data are consistent with our previous animal study and the idea that persistent pain induces the synthesis and release of cystatin C in dorsal spinal cord, the surplus of which overflows into the CSF...
  6. pmc Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control
    Laszlo Karai
    National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892, USA
    J Clin Invest 113:1344-52. 2004
    ..The results suggest that nociceptive neuronal or nerve terminal deletion will be effective and broadly applicable as strategies for pain management...
  7. ncbi request reprint Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model
    Dorothy Cimino Brown
    Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104 6010, USA
    Anesthesiology 103:1052-9. 2005
    ..Following work in laboratory animals, the authors explored the use of intrathecal resiniferatoxin to control spontaneous bone cancer pain in companion (pet) dogs...
  8. ncbi request reprint Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells
    Robert M Caudle
    Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry and the University of Florida McKnight Brain Institute, 1600 Archer Road, P O Box 100416, Gainesville, FL 32610, USA
    Neurotoxicology 24:895-908. 2003
    ..From these data it was concluded that the loss of cell membrane was dependent on the presence of both VR1 and intracellular Ca2+ accumulation, but not on cell phenotype...
  9. ncbi request reprint Complete pain relief: potential problems and diagnostic solutions
    Andrew J Mannes
    Department of Anesthesia and Surgical Services, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892 4410, USA
    Nat Clin Pract Neurol 3:648-9. 2007
  10. pmc Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia
    John K Neubert
    College of Dentistry Department of Orthodontics, University of Florida, Gainesville, FL, USA
    Mol Pain 4:3. 2008
    ..We propose that this method could represent a beneficial treatment for a range of chronic pain problems, including neuropathic and inflammatory pain not responding to other therapies...